Published

PR012/#955 Psilocybin assisted psychotherapy for patients with ovarian caner: a subset analysis of a randomized, double-blind, placebo-controlled, phase II clinical trial

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: International Journal of Gynecological Cancer
Date: 2024-10-01
Source: OpenAlex
DOI: 10.1136/ijgc-2024-igcs.54
PubMed: Unavailable

Authors

Daniel Spinosa Stacy M. Fischer Richard J. Zeifman Carolyn Lefkowits Petros Petridis Stephen Ross

Watch author

Derived topics and classifications

psilocybin Clinical Trial Randomized Controlled Trial Randomized Controlled Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

PR012/#955 Psilocybin assisted psychotherapy for patients with ovarian caner: a subset analysis of a randomized, double-blind, placebo-controlled, phase II clinical trial2024-10-01

Related papers

The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-01-01 Is MDD the right target for early-stage psychedelic-assisted therapy trials?Journal of Psychedelic Studies · 2021-09-15 Psilocybine vergeleken met escitalopram bij depressiePure Amsterdam UMC · 2022-01-17 Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06 Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.Open Access CRIS of the University of Bern · 2026-05-28 Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreatUniversität Zürich, ZORA · 2025-09-29 Psychedelics: The New Kid on the BlockAnnals of Indian Psychiatry · 2024-01-01 Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialUniversität Zürich, ZORA · 2025-04-01